Emergent BioSolutions ( NYSE:EBS ) Third Quarter 2024 Results Key Financial Results Revenue: US$293.8m (up 8.6% from 3Q... Emergent BioSolutions Inc (EBS) reports a robust financial performance ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
At close: November 14 at 4:45 PM GMT+2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback